Table 2
Review of previous studies comparing FNA cytology and NCB in the diagnosis of malignant abdominal lesions
| Diagnostic sensitivity | |||||
|---|---|---|---|---|---|
| Reference | No. malignant cases | Site | FNA | NCB | Combined |
| *Data expressed as “retrieval rate”; includes benign cases; †data derived from table 1, reference 17; ‡data derived from tables 1 and 2, reference 18; §data expressed as “correct diagnosis”. | |||||
| FNA, fine needle aspiration; NCB, needle core biopsy; NS, not specified. | |||||
| Jacobsen and colleagues10 | 48 | Liver | 100 | 80 | 100 |
| Cochond-Priollet and colleagues14 | 26 | Liver | 81 | 69 | 85 |
| *Livraghi and colleagues12 | 200 | Abdomen | 89 | 83 | 98 |
| Bedenne and colleagues11 | 36 | Liver | 83 | 81 | 92 |
| Lin et al and colleagues15 | 59 | Liver | 95 | 89 | NS |
| Solmi and colleagues16 | 42 | Pancreas | 95 | 71 | 95 |
| †Moulton and Moore17 | 118 | Abdomen | 75 | 86 | 91 |
| ‡Tikkakoski and colleagues18 | 49 | Abdomen | 88 | 73 | NS |
| §Nyman and colleagues8 | 55 | Abdomen | 62 | 91 | 93 |
| Dusenbery and colleagues19 | 40 | Liver | 90 | 85 | 98 |
| Our series | 129 | Abdomen | 86 | 82 | 90 |
